Abstract
Effects of urogastrone on gastric and duodenal ulcers were studied with a double blind method.
Urogastrone was given to 16 cases and lactose as placebo to 11 cases, each 4 capsules a day, for 42-56 days.
Clinical effects were evaluated on the basis of pre and post administration subjective symptoms, gastrocamera findings and G. I. X-ray data.
Fourteen cases (87.5%) out of 16 cases subjec t ed to urogastrone showed improvement of ulcer. Eight cases (72.0%) of 11 cases subjected to placebo were improved. It was found that urogastrone were effective, without adverse effects.
